Table 4.
Variables | Total (26 patients) |
---|---|
Age (years) | 71.8 ± 6.7 |
Height (m) | 1.6 ± 0.1 |
Weight (kg) | 64.2 ± 8.5 |
Body mass index (kg/m²) | 24.1 ± 3.1 |
Sex (M:F) | 18:8 |
H&Y stage | 2.2 ± 0.3 |
MMSE | 26.3 ± 3.3 |
MoCA | 23.1 ± 5.0 |
UPDRS total | 35.7 ± 15.2 |
Disease duration (years) | 4.9 ± 2.9 |
Duration of levodopa treatment (years) | 3.7 ± 2.8 |
Levodopa equivalent dose (mg/day) | 450.3 ± 213.7 |
H&Y Hoehn and Yahr, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, UPDRS Unified Parkinson’s Disease Rating Scale.
Values are expressed as mean ± standard deviation.